RecruitingPhase 1NCT07295067

Extracellular Vesicles for the Treatment of Syringomyelia

Studying OBSOLETE: Primary syringomyelia/hydromyelia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Xuanwu Hospital, Beijing
Intervention: Exosomes group(drug)
Enrollment: 18 enrolled
Eligibility: 18-70 years · All sexes
Timeline: 2025 – 2026

Study locations (1)

Xuanwu Hospital, Beijing, Beijing City, China

Collaborators

Yisaier Medical Technology (shan xi) Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07295067 on ClinicalTrials.gov

Other trials for OBSOLETE: Primary syringomyelia/hydromyelia

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT01150708
A Prospective Natural History Study of Patients With Syringomyelia
National Institute of Neurological Disorders and Stroke (NINDS)

See all trials for OBSOLETE: Primary syringomyelia/hydromyelia →

← Back to all trials